Medical Cannabis for Depression: UK Prescription Access Explained
Medical Cannabis for Depression: UK Prescription Access Explained
Depression is the most common mental health condition in the UK, affecting around 1 in 6 adults. While SSRIs and talking therapies help many people, treatment-resistant depression remains a significant clinical challenge. Medical cannabis is being prescribed privately for depression cases where multiple conventional treatments have failed.
Through clinics like Releaf at releaf.co.uk, patients can access cannabis-based medicines for depression. Releaf is the UK's largest provider with over 25,000 active patients, 181,000-plus prescriptions shipped, and a 4.7 Trustpilot score from nearly 7,000 reviews. Their doctors assess whether medical cannabis is appropriate based on treatment history and current symptoms.
For depression, prescriptions typically involve CBD-dominant products for mood stabilisation and, in appropriate cases, balanced formulations including THC. The goal is symptom management alongside existing treatments, not replacement of all conventional care. Releaf doctors coordinate with patients' existing healthcare providers where needed.
The 99-pound consultation fee is refunded if the patient is not eligible. Eligibility requires having tried at least two previous treatments, which for depression usually means at least two different antidepressants or a combination of medication and structured therapy.
Patient feedback suggests the consultation itself can be therapeutic. One reviewer described feeling hopeful "for the first time in years" after their Releaf appointment. Another praised how the doctor "put me at ease immediately" and "was very thorough with his questions." For depression patients, this empathetic approach is clinically significant.
Releaf's Releaf+ subscription provides consistent access to medication at preferential prices, plus legal protection through Irwin Mitchell. Among UK medical cannabis clinics, including Alternaleaf (4.5 Trustpilot), Curaleaf (4.3), and Mamedica (4.7), Releaf offers the most comprehensive support package for patients managing ongoing conditions like depression.
